Related Experiment Video
Updated: Sep 5, 2025

Zebra II as A Novel System to Record Electrophysiological Signals in Zebrafish
Published on: August 16, 2024
Amiodarone Related Skin Toxicity -The Blue Man Syndrome; a Case Report and Review of Literature
Ayesha Safdar1, Talha Ahmed2, Sahar Fatima3
1Department of Medicine, Army Medical College, Rawalpindi, Pakistan.
Abstract:
Amiodarone induced blue-gray syndrome is a rare condition. It develops over years of use of amiodarone and can lead to discontinuation of the drug. It tends to develop over the sun exposed areas of the body typically involving the face and neck. Published medical literature is scarce with regard to the pathogenesis, clinical implications and management of this potential association. We chronicle here the case of a patient with amiodarone induced blue-grey discoloration of skin from our clinical experience. Furthermore, a systematic literature search of the medical databases PubMed and Google Scholar was conducted. A total of 9 cases fulfilled the inclusion criteria. The data on patients' characteristics, epidemiology, clinical features, comorbid conditions, diagnosis, clinical course and outcome were analyzed. The present review outlines our current understanding of the epidemiology and risk factors for amiodarone induced-blue man syndrome, the pathophysiology of this condition and currently available management options.
More Related Videos
08:51Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
Published on: May 12, 2019
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
Related Concept Videos
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias VI: Management of Dysrhythmias